Keywords: bayer/s-p, zetia, approved, japan, japanese, ministry, health
Bayer/S-P's Zetia approved in Japan
Article | 23 April 2007
The Japanese Ministry of Health, Labor and Welfare has approved German drug major Bayer's Zetia (ezetimibe). The novel cholesterol-lowering agent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
